0001209191-23-059998.txt : 20231229
0001209191-23-059998.hdr.sgml : 20231229
20231229162214
ACCESSION NUMBER: 0001209191-23-059998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231227
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Catinazzo Thomas
CENTRAL INDEX KEY: 0001818261
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39385
FILM NUMBER: 231527967
MAIL ADDRESS:
STREET 1: C/O RELAY THERAPEUTICS, INC.
STREET 2: 399 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Relay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001812364
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-370-8837
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-27
0
0001812364
Relay Therapeutics, Inc.
RLAY
0001818261
Catinazzo Thomas
C/O RELAY THERAPEUTICS, INC.
399 BINNEY STREET, 2ND FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-12-27
4
S
0
294
11.51
D
143851
D
Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
Includes 118,359 shares underlying RSUs.
/s/ Brian Adams, as attorney-in-fact
2023-12-29